| 000 | 01117 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515080415.0 | ||
| 264 | 0 | _c20071017 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a1172-7047 | ||
| 024 | 7 |
_a10.2165/00023210-200721090-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBialer, Meir | |
| 245 | 0 | 0 |
_aExtended-release formulations for the treatment of epilepsy. _h[electronic resource] |
| 260 |
_bCNS drugs _c2007 |
||
| 300 |
_a765-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xadministration & dosage |
| 650 | 0 | 4 |
_aCarbamazepine _xadministration & dosage |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xprevention & control |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOxcarbazepine |
| 650 | 0 | 4 | _aTeratogens |
| 650 | 0 | 4 |
_aValproic Acid _xadministration & dosage |
| 773 | 0 |
_tCNS drugs _gvol. 21 _gno. 9 _gp. 765-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00023210-200721090-00005 _zAvailable from publisher's website |
| 999 |
_c17228136 _d17228136 |
||